Pregnancy hormones, pre-eclampsia, and implications for breast cancer risk in the offspring

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 7, 2003, Pages 647-650

  Tamimi, Rulla ^a   Lagiou, Pagona ^a,b   Vatten, Lars J ^c   Mucci, Lorelei ^a   Trichopoulos, Dimitrios ^a,b   Hellerstein, Susan ^d   Ekbom, Anders ^a,e   Adami, Hans Olov ^a,e   Hsieh, Chung Cheng ^a,f,g  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e KAROLINSKA INSTITUTE   (Sweden)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^g UMass Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRIOL; PROGESTERONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN;

ADULT; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER RISK; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREECLAMPSIA; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; PROGESTERONE BLOOD LEVEL; QUESTIONNAIRE; RISK FACTOR;

ADULT; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CHILD; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROGESTERONE; PROSPECTIVE STUDIES; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN;

EID: 0042347645     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Trichopoulos, D. Hypothesis: does breast cancer originate in utero? Lancet, 335: 939-940, 1990.
2. Ekbom, A. Growing evidence that several human cancers may originate in utero. Semin. Cancer Biol., 8: 237-244, 1998.
3. Innes, K. E., and Byers, T. E. Preeclampsia and breast cancer risk. Epidemiology, 10: 722-732, 1999.
4. Isouard, G. Measurement of serum levels of oestriol and human placental lactogen in the management of pre-eclamptic pregnancies. Med. J. Aust., 2: 401-404, 1979.
5. Parker, C. R., Jr., Everett, R. B., Quirk, J. G., Jr., Whalley, P. J., and Gant, N. F. Hormone production during pregnancy in the primigravid patient. I. Plasma levels of progesterone and 5-α-pregnane-3,20-dione throughout pregnancy of normal women and women who developed pregnancy-induced hypertension. Am. J. Obstet. Gynccol., 135: 778-782, 1979.
6. Ranta, T., Stenman, U. H., Unnerus, H. A., Rossi, J., and Seppala, M. Maternal plasma prolactin levels in preeclampsia. Obstet. Gynecol., 55: 428-430, 1980.
7. Rosing, U., and Carlstrom, K. Serum levels of unconjugated and total oestrogens and dehydroepiandrosterone, progesterone and urinary oestriol excretion in pre-eclampsia. Gynecol. Obstet. Investig., 18: 199-205, 1984.
8. Lipworth, L., Hsieh, C-C., Wide, L., Ekbom, A., Yu, S-Z., Yu, G-P., Xu, B., Hellerstein, S., Carlstrom, K., Trichopoulos, D., and Adami, H-O. Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br. J. Cancer, 79: 7-12, 1999.
9. Wuu, J., Hellerstein, S., Lipworth, L., Wide, L., Xu, B., Yu, G. P., Kuper, H., Lagiou, P., Hankinson, S. E., Ekbom, A., Carlstrom, K., Trichopoulos, D., Adami, H. O., and Hsieh, C-C. Correlates of pregnancy oestrogen, progesterone and sex hormone-binding globulin in the USA and China. Eur. J. Cancer Prev., 11: 283-293, 2002.
10. Xu, B., Lipworth, L., Wide, L., Wuu, J., Yu, S. Z., Lagiou, P., Kuper, H., Hankinson, S. E., Carlstrom, K., Adami, H. O., Trichopoulos, D., and Hsieh, C-C. Maternal and gestational correlates of pregnancy prolactin and growth hormone in USA and China. Eur. J. Cancer Prev., 12: 35-42, 2003.
11. Walsh, S. W. Progesterone and estradiol production by normal and pre-eclamptic placentas. Obstet. Gynecol., 71: 222-226, 1988.
12. Acromite, M. T., Mantzoros, C. S., Leach, R. E., Hurwitz, J., and Dorey, L. G. Androgens in preeclampsia. Am. J. Obstet. Gynecol., 180: 60-63, 1999.
13. Serin, I. S., Kula, M., Basbug, M., Unluhizarci, K., Gucer, S., and Tayyar, M. Androgen levels of preeclamptic patients in the third trimester of pregnancy and six weeks after delivery. Acta Obstet. Gynecol. Scand., 80: 1009-1013, 2001.
14. Wald, N. J., and Morris, J. K. Multiple marker second trimester serum screening for pre-eclampsia. J. Med. Screen., 8: 65-68, 2001.
15. Stamilio, D. M., Sehdev, H. M., Morgan, M. A., Propert, K., and Macones, G. A. Can antenatal clinical and biochemical markers predict the development of severe preeclampsia? Am. J. Obstet. Gynecol., 182: 589-594, 2000.
16. Wolf, M., Sandler, L., Munoz, K., Hsu, K., Ecker, J. L., and Thadhani, R. First trimester insulin resistance and subsequent preeclampsia: a prospective study. J. Clin. Endocrinol. Metab., 87: 1563-1568, 2002.
17. Ros, H. S., Cnattingius, S., and Lipworth, L. Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am. J. Epidemiol., 147: 1062-1070, 1998.
18. Odegard, R. A., Vatten, L. J., Nilsen, S. T., Salvesen, K. A., and Austgulen, R. Risk factors and clinical manifestations of pre-eclampsia. BJOG, 107: 1410-1416, 2000.
19. Troisi, R., Weiss, H. A., Hoover, R. N., Potischman, N., Swanson, C. A., Brogan, D. R., Coates, R. J., Gammon, M. D., Malone, K. E., Daling, J. R., and Brinton, L. A. Pregnancy characteristics and maternal risk of breast cancer. Epidemiology, 9: 641-647, 1998.
20. Peck, J. D., Hulka, B. S., Poole, C., Savitz, D. A., Baird, D., and Richardson, B. E. Steroid hormone levels during pregnancy and incidence of maternal breast cancer. Cancer Epidemiol. Biomark. Prev., 11: 361-368, 2002.